The regulatory landscape for the safety evaluation, clinical testing and commercial development of medical devices is undergoing considerable changes, including new requirements for material characterization and chemical risk assessment early on in the development process. In this webinar, toxicologist Dr. Joel Cohen (Gradient), and chemists Dr. Mark Jordi (Jordi Labs), and Dr. Jim Rice (Gradient) will discuss strategies for evaluating safety and biocompatibility of a device from the development stage through to market approval.